Stay updated on Omalizumab in CRSwNP: Clinical Trial

Sign up to get notified when there's something new on the Omalizumab in CRSwNP: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Omalizumab in CRSwNP: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T06:28:26.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer site revision changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T05:11:50.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-11T08:15:48.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The study page for NCT04583501 now renders a 403 Forbidden error instead of displaying the study record. The page shows a basic error message along with the site header and footer.
    Difference
    16%
    Check dated 2026-09-20T03:46:42.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, representing a minor update to the study page's metadata. No study content, eligibility criteria, or results are changed.
    Difference
    0.1%
    Check dated 2026-08-30T00:35:39.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    No additions or deletions were provided for this page, so the content remains as published.
    Difference
    0.1%
    Check dated 2026-08-16T01:27:27.000Z thumbnail image

Stay in the know with updates to Omalizumab in CRSwNP: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Omalizumab in CRSwNP: Clinical Trial page.